Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
NASDAQ Global Market · Equity
$33.8081
+$0.0531 · +0.16%
· Aug 21, 4:00 PM ET
$33.8081
Previous close+$0.0531 · +0.16%
· Aug 21, 4:00 PM ET
$33.80
+$0.045 · +0.13%
Regular session · ET · Market data may be delayed.
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Fund assets
65.24M USD
Expense ratio
0.59%
NAV
$33.80
Average volume
21.99K
Volume
15.28K
Day range
$33.68 – $34.11
52-week range
$25.244 – $37.15
Previous close
$33.755
Price change
1 day
+0.16%
1 month
+4.93%
3 months
+8.29%
Year to date
-1.03%
1 year
+33.16%
3 years
+33.26%
5 years
+33.26%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Dec 30, 2025
Irregular
Dec 30, 2025
Dec 31, 2025
$0.4099
Dec 30, 2024
Annual
Dec 30, 2024
Dec 31, 2024
$0.0531
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
